Jain Global »

Iovance Biotherapeutics shares owned by Jain Global

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Jain Global from 13F filings

Historical chart of Jain Global investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Jain Global consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Jain Global

Quarter filed Position value Share count Share price at filing
2025-12-31 $852k 312k 2.73
2025-06-30 $141k 82k 1.72
2025-03-31 $74k 22k 3.33

More positions owned by Jain Global

Spdr Gold Tr Gold Shs (GLD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Vaneck Etf Trust Gold Miners Etf (GDX)
Tesla Motors (TSLA)
Boeing Company (BA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
NVIDIA Corporation (NVDA)
Vaneck Etf Trust Junior Gold Mine (GDXJ)
Alphabet Cap Stk Cl A (GOOGL)
Select Sector Spdr Tr State Street Fin Call Option (XLF)
Spdr Series Trust State Street Spd Call Option (KRE)

View all positions for Jain Global

Top funds holding Iovance Biotherapeutics

BlackRock
MHR Fund Management
Vanguard Group
State Street Corporation
Invenomic Capital Management
Goldman Sachs Group
Long Focus Capital Management
Geode Capital Management
Palo Alto Investors
Susquehanna International
Citadel Advisors
Millennium Management
Hrt Financial
Jane Street
Charles Schwab Investment Management

View all funds holding Iovance Biotherapeutics